Albert David
Albert David Share Price Chart
Albert David last traded at ₹781.50 (2026-10-13). Over the past month the stock moved -8.6%, three months the stock moved +9.2%, year the stock moved -2.5%. Its closing range over 52 weeks is ₹607.75 – ₹905.00, with the latest close 13.6% below the high.
Closing prices up to 2026-10-13.
About Albert David
Incorporated in 1938, Albert David Ltd is in the business of manufacturing pharmaceutical products[1]
Business Overview:[1] ADL is a part of the Kolkata-based Kothari Group. It is a prominent drug house, which is in the field of manufacturing Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms, Bulk Drugs, etc. Company is in strategic liaison with academic institutes like the Indian Institute of Chemical Biology (CSIR) & Department of Biotechnology, Calcutta University for outsourcing research.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Albert David reported sales of ₹101.00 crore (+42.3%) and net profit of ₹32.00 crore (+300.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 101.00 | 11.00 | 10.00 | 32.00 | 56.07 |
| Mar 2026 | 86.00 | 3.00 | 3.20 | -21.00 | -37.55 |
| Dec 2025 | 90.00 | 11.00 | 12.00 | 15.00 | 26.81 |
| Sep 2025 | 87.00 | 3.00 | 2.90 | -3.00 | -5.78 |
| Jun 2025 | 71.00 | -11.00 | -15.00 | 8.00 | 13.91 |
| Mar 2025 | 75.00 | -5.00 | -6.00 | -10.00 | -18.10 |
| Dec 2024 | 83.00 | 1.00 | 0.80 | -9.00 | -16.45 |
| Sep 2024 | 98.00 | 6.00 | 6.00 | 18.00 | 31.66 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +5.4% | -5.7% | -15.7% | -20.2% | -11.2% | +8.4% | +14.7% | +42.3% |
| Operating profit growth | -62.5% | -87.5% | -150.0% | -1200.0% | -50.0% | +1000.0% | – | – |
| Net profit growth | -10.0% | -147.4% | -176.9% | -57.9% | -116.7% | – | – | +300.0% |
| EPS growth | -11.0% | -150.2% | -180.0% | -57.9% | -118.3% | – | – | +303.1% |
| OPM % | 6.0% | 0.8% | -6.0% | -15.0% | 2.9% | 12.0% | 3.2% | 10.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Albert David reported sales of ₹334.00 crore (-3.2%) and net profit of ₹-1.00 crore (-105.9%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 334.00 | 5.00 | 2.00 | -1.00 | -2.61 |
| Mar 2025 | 345.00 | 3.00 | 1.00 | 17.00 | 30.14 |
| Mar 2024 | 362.00 | 47.00 | 13.00 | 75.00 | 132.15 |
| Mar 2023 | 341.00 | 44.00 | 13.00 | 36.00 | 63.38 |
| Mar 2022 | 313.00 | 41.00 | 13.00 | 35.00 | 61.78 |
| Mar 2021 | 246.00 | 19.00 | 8.00 | 22.00 | 38.79 |
| Mar 2020 | 320.00 | 30.00 | 10.00 | 19.00 | 33.59 |
| Mar 2019 | 316.00 | 30.00 | 10.00 | 27.00 | 46.68 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +10.9% | +1.3% | -23.1% | +27.2% | +8.9% | +6.2% | -4.7% | -3.2% |
| Operating profit growth | +66.7% | +0.0% | -36.7% | +115.8% | +7.3% | +6.8% | -93.6% | +66.7% |
| Net profit growth | +170.0% | -29.6% | +15.8% | +59.1% | +2.9% | +108.3% | -77.3% | -105.9% |
| EPS growth | +170.8% | -28.0% | +15.5% | +59.3% | +2.6% | +108.5% | -77.2% | -108.7% |
| OPM % | 10.0% | 10.0% | 8.0% | 13.0% | 13.0% | 13.0% | 1.0% | 2.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Albert David.
Get Free AI Stock Analysis FREE →Latest News
-
Volume Gainers, August 7, 2026, 11:30 AM IST: Indraprastha Medical, Albert David, The Sandesh Among Stocks in Focus
-
Albert David Standalone March 2026 Net Sales at Rs 85.86 crore, up 14.65% Y-o-Y - Moneycontrol.com
-
Albert David Standalone March 2026 Net Sales at Rs 85.86 crore, up 14.65% Y-o-Y - Moneycontrol.com
-
Albert David Standalone March 2026 Net Sales at Rs 85.86 crore, up 14.65% Y-o-Y - Moneycontrol.com
-
Albert David Standalone March 2026 Net Sales at Rs 85.86 crore, up 14.65% Y-o-Y - Moneycontrol.com
-
Albert David Standalone March 2026 Net Sales at Rs 85.86 crore, up 14.65% Y-o-Y - Moneycontrol.com
-
Albert David Reports FY26 Net Loss of ₹149.47 Lakh, Declares Final Dividend - scanx.trade
-
Albert David Standalone March 2026 Net Sales at Rs 85.86 crore, up 14.65% Y-o-Y - Moneycontrol.com
-
Albert David Reports FY26 Net Loss of ₹149.47 Lakh, Declares Final Dividend - scanx.trade
-
Albert David Standalone March 2026 Net Sales at Rs 85.86 crore, up 14.65% Y-o-Y - Moneycontrol.com
Frequently Asked Questions
What is the share price of Albert David today?
Albert David shares were last quoted at ₹781.50 (-1.3% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Albert David?
Albert David has a price-to-earnings (P/E) ratio of 21.48 and a price-to-book (P/B) ratio of 1.14. The industry P/E is 52.82.
What is the 52-week high and low of Albert David?
The 52-week high of Albert David is ₹925.00 and the 52-week low is ₹581.30.
What is the market cap of Albert David?
The market capitalisation of Albert David is about ₹484.74 crore.
How did Albert David perform in its latest quarterly results?
In the latest quarter (Jun 2026), Albert David reported sales of ₹101.00 crore (+42.3%) and net profit of ₹32.00 crore (+300.0%), compared with the same quarter last year.
Is Albert David a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Albert David has a 3-year ROE of 8.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Albert David?
Promoters hold about 62.24% of Albert David.
Which sector does Albert David belong to?
Albert David belongs to the Pharmaceuticals & Drugs sector.